Feedback / Questions
dectrekumab (QAX576) - Novartis
Novartis: Q4 & FY 2015 Results
(Novartis)
-
Jan 29, 2016 -
Anticipated regulatory submission for allergic diseases in 2020 or later
Anticipated regulatory
•
Immunology
https://www.novartis.com/sites/novartisemea.prod.acquia-sites.com/files/q4-2015-ir-presentation.pdf
Jan 29, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.